Instagram and Podcast Intervention for Breast Cancer Awareness and Screening

NCT07673588 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-08-03

No results posted yet for this study

Summary

Breast cancer is the most common cancer among women worldwide. This randomized controlled trial aims to evaluate the effect of an Instagram- and podcast-based intervention on women's breast cancer awareness, health beliefs, and breast cancer screening behaviors among women aged 20-39 years.

Conditions

Interventions

OTHER

Instagram-Based Breast Cancer Awareness Intervention

Participants will follow the "Breast Health Academy" Instagram account and receive an 8-week Instagram-based breast cancer awareness intervention. Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays. Reminder stories encouraging breast self-examination (BSE), such as "Do not forget to perform your monthly BSE" and "Remember to perform BSE this week," will be shared on Tuesdays, Thursdays, and Sundays. Stories will also be saved as highlights. No content will be shared on Fridays, and all posts and stories will be published at the same time each day.

OTHER

Instagram-Podcast-Based Breast Cancer Awareness Intervention

Participants will follow the "Breast Health Academy Plus" Instagram account and receive an 8-week Instagram- and podcast-based breast cancer awareness intervention. Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays. Reminder stories encouraging breast self-examination (BSE) will be shared on Tuesdays, Thursdays, and Sundays and saved as highlights. In addition, one educational podcast episode developed for the intervention will be delivered weekly via Instagram direct message every Friday. All content will be provided at the same time each day throughout the intervention period.

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Baise Bicav · Yüksek İhtisas University

  • Zehra Bicav · Yüksek İhtisas University

  • Sevinç Kutlutürkan · Ankara University

  • Filiz Ünal Toprak · Saglik Bilimleri Universitesi

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-06
Primary Completion
2026-10-06
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07673588 on ClinicalTrials.gov